Delivery Order SPE2DB22D3301-SPE2DB25FZ1RD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Epidiolex 100 mg/mL solution in a 100 mL pack, with a contract ceiling value of $1,682.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for ultimate completion by June 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,523.75 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Epidiolex 100 mg/ml solution in 100ml packs. This is a firm fixed-price delivery order with a completion date of September 23, 2025, and represents a non-set-aside competitive award. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs, with a ceiling value of $1,682.50 and an ultimate completion date of September 8, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with a ceiling value of $1,682.50 and an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with a ceiling value of $1,280.92 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 2, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epidiolex 100 mg/ml solution in 100ml packs, with a ceiling value of $1,682.50 and a firm fixed price structure. This delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $3,842.76. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with a ceiling value of $1,481.70 and an ultimate completion date of October 7, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with the federal government. The place of performance is located...
- The Defense Logistics Agency awarded a $3,365.00 delivery order to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs, with an ultimate completion date of September 5, 2025. This is a firm fixed price, non-set-aside delivery order sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the company's Conshohocken,...
- The Defense Logistics Agency awarded a $1,280.92 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with an ultimate completion date of October 6, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol medication used primarily for...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1RDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,190.00 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. The contract is a firm fixed price delivery order with an ultimate completion date of October 20, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies critical medications and medical supplies across multiple therapeutic domains to support military healthcare systems and other government agencies. The current order for Epidiolex, an FDA-approved seizure medication, represents a routine fulfillment under this expansive global pharmaceutical support vehicle designed to meet Defense Health Agency and other federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 9/26/25 |